M L 6 (Levothyroxine Sodium 75 mcg (0.075 mg))

Pill with imprint M L 6 is Purple, Capsule-shape and has been identified as Levothyroxine Sodium 75 mcg (0.075 mg). It is supplied by Mylan Pharmaceuticals Inc..

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 75 mcg (0.075 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L 6

Levothyroxine sodium 75 mcg (0.075 mg) M L 6 Front

Levothyroxine sodium 75 mcg (0.075 mg) M L 6 Back

Levothyroxine Sodium

Imprint: M L 6
Strength: 75 mcg (0.075 mg)
Color: Purple
Size: 9.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Thyroid drugs
Pregnancy Category: A - Studies show no risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Mylan Pharmaceuticals Inc.
Inactive Ingredients: butylated hydroxyanisole, silicon dioxide, magnesium stearate, mannitol, microcrystalline cellulose, sodium lauryl sulfate, sucrose, FD&C Blue No. 2, FD&C Red No. 40
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00378-1805	Mylan Pharmaceuticals Inc.
51079-0441	UDL Laboratories Inc.
54569-5653	A-S Medication Solutions, LLC (repackager)
49999-0793	Lake Erie Medical and Surgical Supply (repackager)